Browse > Article

The Effect of a Potential Antiobesity-Supplement on Weight Loss and Visceral Fat Accumulation in Overweight Women  

차보람 (연세대학교 식품영양학과, 의과대학 심장내과)
채지숙 (연세대학교 식품영양학과, 의과대학 심장내과)
이종호 (연세대학교 식품영양학과, 의과대학 심장내과)
장양수 (연세대학교 식품영양학과, 의과대학 심장내과)
이진희 (CJ(주) 식품연구소)
손종욱 (CJ(주) 식품연구소)
Publication Information
Journal of Nutrition and Health / v.36, no.5, 2003 , pp. 483-490 More about this Journal
Abstract
Chitosan, hydroxycitrate and L-carnitine have been known to be antiobesity components. The purpose of this study was to evaluate the combined effects of chitosan, hydroxycitrate and L-carnitine mixture as a potential antiobesity supplement in overweight women. Pre-menopausal healthy females who were overweight (percent ideal body weight > 110) were included in this study. Forty-nine subjects randomly received a placebo (n = 25) or antiobesity-supplement (n = 24), which was a mixture of chitosan, hydroxycitrate, and L-carnitine. Before and after the eight-week experimental period, anthropometric parameters, blood components and computerized tomography were measured. At baseline, the two groups were well matched in terms of age, body mass index and lipid profile. After the eight weeks of potential antiobesity supplementation, the subjects' body fat percent had decreased significantly (p < 0.001) by 5.6% (39.1 $\pm$ 1 vs 36.9 $\pm$ 1%) while lean body mass increased (p < 0.01). Vsceral fat area at the L4 vertebra decreased significantly (p < 0.01) by 8.6% in the supplemented group and the total fat area at the L4 vertebra showed a tendency to decrease (p = 0.051) by 2.4%. Also, in the group given the antiobesity-supplement rather than the placebo, the fasting triglyceride level decreased significantly (p < 0.05) by 10.0%. In addition, serum total cholesterol levels in the antiobesity-supplement group showed a tendency to decrease (p=0.159) by 2.7% (194 $\pm$ 6 vs 189 $\pm$ 6 mg/dl). No side effects were found in either group during the intervention. In conclusion, the present study demonstrated that taking a mixture of chitosan, hydroxycitrate, and L-carnitine as a potential antiobesity supplement for eight weeks produced advantageous changes in the weight and visceral fat accumulation of overweight women without any side effects. (Korean J Nutrition 36(5): 483~490, 2003)
Keywords
overweight; chitosan; hydroxycitrate; L-carnitine; weight loss; visceral fat area;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Randomized,double-blind trial of chitosan of chitosan for body weight reduction /
[ Pittler,M.H.;Abbot,N.C.;Harkness,E.F.;Ernst,E. ] / Eur J Clin Nutr   DOI   ScienceOn
2 Impact of overweight on the risk of developing common chronic diseases during a 10-year period /
[ Field,A.E.;Coakley,E.H.;Must,A.;Spadano,J.L.;Laird,N.;Dietz,W.H.;Rimm,E.;Colditz,G.A. ] / Arch Intern Med   DOI   ScienceOn
3 Chemistry and biochemistry of (-) hydroxycitric acid from Garcinia /
[ Jena,B.S.;Jayaprakasha,G.K.;Singh,R.P.;Sakariah,K.K. ] / J Agric Food Chem   DOI   ScienceOn
4 A non-prescription alternative on weight reduction therapy /
[ Conte,A.A. ] / Am J Bariatr Med summer
5 Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent:a randomized controlled trial /
[ Heymsfield,S.B.;Allison,D.B.;Vasselli,J.R.;pietrobelli,A.;Greenfield,D.;Nunez,C. ] / JAMA   DOI   ScienceOn
6 Persons successful at long-term weight loss and maintenance continue to consume a low-energy, low-fat diet /
[ Shick,S.M.;Wing,R.R.;Klem,M.L.;McGuire,M.T.;Hill,J.O.;Seagle,H. ] / J Am Diet Assoc   DOI   ScienceOn
7 A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans /
[ Gallaher,D.D.;Gallaher,C.M.;Mahrt,G.J.;Carr,T.P.;Hollingashead,C.H.;Hesslink,R. Jr.;Wise,J. ] / J Am Coll Nutr   DOI
8 Effect of (-)hydroxycitrate upon the accumulation of lipid in the rat /
[ Sullivan,A.C.;Triscari,J.;Hamilton,J.G.;Miller,O.N.;Wheatley,V.R. ] / I. Lipogenesis.Lipids
9 The effect of (-) hydroxycitrate on energy intake and satiety in overweight humans /
[ Westerterp-Plantenga, M.S.;Kovacs,E.M. ] / Int J Obes Relat Metab Disord   DOI
10 Clinical and biochemical evaluation of chitosan for hypercholesterolemia and overweight control /
[ Muzzarelli,R.A. ] / EXS
11 /
[ Clouatre,D.;Rosenbaum,M. ] / The diet and health benefits of HCA(Hydroxycitric acid)
12 Changes in carnitine metabolism with ketone body production in obese glucose-intolerant patients /
[ Inokuchi,T.;Imamura,K.;Nomura,K.;Nomoto,K.;Isogai,S. ] / Diabetes Res Clin Pract   DOI   ScienceOn
13 Comparative evaluation of fecal fat excretion induced by orlistat and chitosam /
[ Guerciolini,R.;Radu-Radulescu, L.;Boldrin,M.;Dallas,J.;Moore,R. ] / Obes Res   DOI
14 Carnitine-metabolism and functions /
[ Bremer,J. ] / Physiol Rev
15 Decrease in serum LDL cholesterol with microcrystalline chitosan /
[ Wuolijoki,E.;Hirvela,T.;Ylitalo,P. ] / Methods Find Exp Clin Pharmacol   DOI   ScienceOn
16 Managing overweight and obesity in women /
[ Klauer,J.;Aronne,L.J. ] / Clin Obstet Gynecol   DOI   ScienceOn
17 Hypocholesterolemic effect of human growth hormone in coronary. Prone (type A) hypercholesterolemic subjects /
[ Friedman,M.;Byers,S.O.;Rosenman,R.H.;Li,C.H. ] / Pro Soc Exp Biol Med   DOI
18 L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women /
[ Villani,R.G.;Gannon,J.;Self,M.;Rich,P.A. ] / Int J Sport Nutr Exerc Metab
19 Management of overweight and obese adults /
[ Noel,P.H.;Pugh,J.A. ] / BMJ   DOI   ScienceOn
20 Carnitine metabolism in normal-weight and obese human subjects during fasting /
[ Hoppel,C.L.;Genuth,S.M. ] / Am J physiol
21 A randomized, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin /
[ Thom,E. ] / J Int Med Res   DOI   ScienceOn